Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025

About this update from Zealand Pharma A/s

[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6gUCOEdJjLHihlE.VvDQtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Press release – No. 8 / 2025","length":28,"tagName":"p"},{"type":"text","content":"Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025","length":94,"tagName":"p"},{"type":"text","content":"Copenhagen, Denmark, May 12, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the company will participate in the following healthcare investor conferences in May and June 2025:","length":314,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Bank of America Global Healthcare Conference, May 13-15 in Las Vegas","length":68,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":68,"olType":false},{"type":"text","content":"David Kendall, Executive Vice President and Chief Medical Officer, will present on Wednesday, May 14 at 8:00am PT (5:00pm CET).","length":127,"tagName":"p"},{"type":"text","content":"A live audio webcast of the presentation will be available at https://bofa.veracast.com/webcasts/bofa/healthcare2025/id0V27z5.cfm.","length":130,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Berenberg European Conference, May 20-22 in New York","length":52,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":52,"olType":false},{"type":"text","content":"Adam Steensberg, President and Chief Executive Officer, to host investor meetings on Tuesday, May 20.","length":101,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Barclays European Leadership Conference, May 22 in London","length":57,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":57,"olType":false},{"type":"text","content":"David Kendall, Executive Vice President and Chief Medical Officer to participate in a ...

More updates from Zealand Pharma A/s